Categories
Pharmaceutical

Targeted Drug Delivery Type to Gain Maximum Traction in the Global Drug Delivery Systems Market – Fact.MR Analyst

250 Pages Drug Delivery Systems Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Drug Delivery Systems to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Drug Delivery Systems market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=4768

The global drug delivery systems market shall register an upswing, expanding at a strong CAGR of 7.0% during the forecast period (2021-2031). Rising incidences of severe chronic and infectious diseases over the past five decades has boosted demand for drug development.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Drug Delivery Systems market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Drug Delivery Systems

The report offers actionable and valuable market insights of Drug Delivery Systems. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Drug Delivery Systems Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Drug Delivery Systems, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Drug Delivery Systems Market.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4768 

Global Drug Delivery Systems: Market Segmentation

Fact.MR has studied the global drug delivery systems market with detailed segmentation on the basis of delivery system, route of administration, application and region.

Delivery System

  • Intra Uterine Implants
  • Pro-drug Implants
  • Polymeric Drug Delivery
  • Targeted Drug Delivery

Route of Administration

  • Oral
  • Injectable
  • Inhalation
  • Transdermal
  • Ocular
  • Nasal
  • Topical

Application

  • Infectious Disease
  • Oncology
  • Ophthalmology
  • Urology
  • Diabetes
  • CNS
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4768

Global Drug Delivery Systems Market Manufacturers

The existing global drug delivery systems market is highly competitive, attributed to the presence of multiple local as well as global manufacturers of drug delivery products. The market is characterized by extensive research efforts and technological advancements. Investment in R&D to develop new grade drug delivery products and addressing complications, concerns and side-effects of their usage characterize the intense rivalry amongst market players.

Some prominent manufacturers in the market include, but are not limited to, Boston Scientific Corporation, Johnson and Johnson Services, Inc., Pfizer, Inc., Baxter International, Inc., Amgen, Inc., Novartis AG, F. Hoffmann La-Roche Ltd., and Bayer AG.

Novartis AG recently acquired a patent in February 2020 for the development of thermogelling peptide delivery systems which are injected as fluid sol at ambient temperature via an injection. The company also manufactures the ZYKADIA for the treatment of non-small lung cancer.

The company also manufactures Binocrit, a medicine to treat symptomatic anemia associated with chronic renal failure among adults as well as pediatric patients. Pfizer, Inc., another prominent market player, provides the iSecure, ABBOJECT and CARPUJECT syringe systems. Additionally, it also offers IV drug delivery systems such as the ADD-Vantage ADDaptor delivery system.

Key Takeaways of Global Drug Delivery Systems Market Study:

  • By delivery type, targeted drug delivery shall grow at a CAGR of 6.8%, accounting for almost half of the global drug delivery systems market. However, polymeric drug delivery is expected to grow the fastest at the rate of 7.3% during the forecast period. Use of nanotechnology and localized drug delivery are key growth drivers for both segments.
  • By application, the oncology segment shall expand the fastest at a CAGR of 7.5% while the CNS segment shall grow at a CAGR of 6.9%. Rising prevalence of cancer and neurological disorders have boosted the demand for enhanced drug delivery devices, thus boosting the overall market share.
  • By route of administration, the injectables segment shall capture a major chunk of the global drug delivery systems market, constituting 44.6% market share. The oral segment is close behind, capturing nearly 2/5th of the global drug delivery systems market. Faster drug delivery at the affected site drives the growth of the injectables segment while advancements in oral drug formulations such as solid lipid nanoparticles shall drive the growth of the oral drugs segment.
  • By region, North America shall dominate the global drug delivery systems market, capturing nearly 40% of the market. At the same time, Asia-Pacific shall expand the fastest, at a CAGR of 7.8% across the forecast period. Increasing prevalence of acute chronic infections, introduction of advanced drug delivery devices and systems and favorable reimbursement policies for key players shall drive growth in both regions.

“Introduction of nanotechnology, coupled with three-dimensional printing and strengthening of existing and new drugs are poised to act as important growth stimulators of the global drug delivery systems market. Key manufacturers are exploiting the available opportunities to consolidate their foothold within the market,” concludes a Fact.MR analyst.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Drug Delivery Systems Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Drug Delivery Systems Historical volume analysis: The report provides a comparison of Drug Delivery Systems’s historical sales and projected sales performance for 2021-2031.
  • Drug Delivery Systems Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Drug Delivery Systems market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Drug Delivery Systems Consumption by demographics: The report investigates consumer behavior affecting Drug Delivery Systems demand outlook for the assessment period. Effect of their keenness for digital trends on Drug Delivery Systems market is carefully analyzed
  • Post COVID consumer spending on Drug Delivery Systems: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Drug Delivery Systems market growth.

More Valuable Insights on Drug Delivery Systems Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Drug Delivery Systems, Sales and Demand of Drug Delivery Systems, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Business

Increasing Prevalence Of Cancers Have Boosted The Demand For Advanced Drug Delivery Systems

Global Drug Delivery Systems Market Growth

The global drug delivery systems market shall register an upswing, expanding at a strong CAGR of 7.0% during the forecast period (2020-2025). Rising incidences of severe chronic and infectious diseases over the past five decades has boosted demand for drug development.

The WHO estimates that over 70 million individuals have been infected by deadly diseases such as HIV. Such trends have naturally pushed healthcare practitioners to develop enhanced drugs and their delivery systems.

Request Sample   https://www.factmr.com/connectus/sample?flag=S&rep_id=4768

The ongoing COVID-19 pandemic shall heighten prospects of drug delivery systems. As the number of infections increase exponentially every day, hospitals and clinics are facing extreme shortages of essential medical equipment such as respirators and ventilators.

To address this shortage, leading pharmaceutical and healthcare companies have accelerated production of essential drug delivery systems. The easing of lockdowns and social distancing measures is expected to restore production cycles to a significant extent, leading to better output and addressing acute shortfalls in the supply of drug delivery devices and systems.

Global Drug Delivery Systems Market: Technological Insights

Several advancements have been made in the field of drug delivery systems. The most significant of them is the incorporation of three-dimensional printing (3D-printing). 3D-printing is a unique prototyping drug delivery technology. It can easily overcome problems associated with the delivery of less water soluble potent drugs, peptides and multi-drugs.

The technology can produce solid dosage forms with multiple drugs and excipients, complex internal geometries, variable diffusivities and densities. Similarly, electronic drug delivery drug systems are gaining huge traction in the market.

Request Customization https://www.factmr.com/connectus/sample?flag=RC&rep_id=4768

Global Drug Delivery Systems: Market Segmentation

Fact.MR has studied the global drug delivery systems market with detailed segmentation on the basis of delivery system, route of administration, application and region.

Delivery System

  • Intra Uterine Implants
  • Pro-drug Implants
  • Polymeric Drug Delivery
  • Targeted Drug Delivery

Route of Administration

  • Oral
  • Injectable
  • Inhalation
  • Transdermal
  • Ocular
  • Nasal
  • Topical

Application

  • Infectious Disease
  • Oncology
  • Ophthalmology
  • Urology
  • Diabetes
  • CNS
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Buy Now  https://www.factmr.com/checkout/4768

Global Drug Delivery Systems Market Manufacturers

The existing global drug delivery systems market is highly competitive, attributed to the presence of multiple local as well as global manufacturers of drug delivery products. The market is characterized by extensive research efforts and technological advancements. Investment in R&D to develop new grade drug delivery products and addressing complications, concerns and side-effects of their usage characterize the intense rivalry amongst market players.

Some prominent manufacturers in the market include, but are not limited to, Boston Scientific Corporation, Johnson and Johnson Services, Inc., Pfizer, Inc., Baxter International, Inc., Amgen, Inc., Novartis AG, F. Hoffmann La-Roche Ltd., and Bayer AG.

Novartis AG recently acquired a patent in February 2020 for the development of thermogelling peptide delivery systems which are injected as fluid sol at ambient temperature via an injection. The company also manufactures the ZYKADIA for the treatment of non-small lung cancer.

The company also manufactures Binocrit, a medicine to treat symptomatic anemia associated with chronic renal failure among adults as well as pediatric patients. Pfizer, Inc., another prominent market player, provides the iSecure, ABBOJECT and CARPUJECT syringe systems. Additionally, it also offers IV drug delivery systems such as the ADD-Vantage ADDaptor delivery system.

For More Insights- https://www.biospace.com/article/rising-prevalence-of-gastric-disorders-increasing-the-sales-in-nizatidine-market-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Targeted Drug Delivery Type to Gain Maximum Traction in the Global Drug Delivery Systems Market – Fact.MR Survey

250 Pages Drug Delivery Systems Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Drug Delivery Systems to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Drug Delivery Systems market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=4768

The global drug delivery systems market shall register an upswing, expanding at a strong CAGR of 7.0% during the forecast period (2021-2031). Rising incidences of severe chronic and infectious diseases over the past five decades has boosted demand for drug development.

To offer an in-depth overview, the report provides sales projections for over 20 countries. It also identifies segments exhibiting maximum growth.

Digital Transformation in Healthcare Presenting Opportunities for Drug Delivery Systems Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Drug Delivery Systems market.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Drug Delivery Systems market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Drug Delivery Systems

The report offers actionable and valuable market insights of Drug Delivery Systems. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Drug Delivery Systems Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Drug Delivery Systems, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Drug Delivery Systems Market.

Global Drug Delivery Systems: Market Segmentation

Fact.MR has studied the global drug delivery systems market with detailed segmentation on the basis of delivery system, route of administration, application and region.

Delivery System

  • Intra Uterine Implants
  • Pro-drug Implants
  • Polymeric Drug Delivery
  • Targeted Drug Delivery

Route of Administration

  • Oral
  • Injectable
  • Inhalation
  • Transdermal
  • Ocular
  • Nasal
  • Topical

Application

  • Infectious Disease
  • Oncology
  • Ophthalmology
  • Urology
  • Diabetes
  • CNS
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4768 

Global Drug Delivery Systems Market- Scope Of The Report

The recent study by Fact.MR on the global drug delivery systems market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends that are currently determining the growth of the global drug delivery systems market.

This report explicates on vital dynamics such as the drivers, restraints and opportunities for key market players along with key stakeholders as well as emerging players associated with the production of drug delivery systems. The study also provides dynamics responsible for influencing the future status of the drug delivery systems market over the forecast period.

A detailed assessment of the global drug delivery systems market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the global drug delivery systems market along with their product portfolio enhances the reliability of this comprehensive research study.

Global Drug Delivery Systems Market: Report Summary

The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in global drug delivery systems markets across the globe.

A comprehensive estimate of the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales in the global drug delivery systems market during the forecast period. Price point comparison by region with global average price is also considered in the study.

Global Drug Delivery Systems Market: Analysis on Market Size Evaluation

The global drug delivery systems market has been analyzed for each market segment, in terms of value (US$ Mn).

Market estimates at global and regional levels for global drug delivery systems is available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent global drug delivery systems market segments, along with market attractiveness evaluation, has been incorporated in the report.

Global Drug Delivery Systems Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the global drug delivery systems report, which have helped deliver projection on the regional markets. These chapters include the regional macros (economic, and business environment outlook), which are expected to have a momentous influence on the growth of the global drug delivery systems market during the forecast period.

Country-specific valuation on demand for global drug delivery systems has been offered for each regional market, along with the market scope estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value for emerging countries has also been included in the report.

Global Drug Delivery Systems Market: In-Depth Analysis on Competitive Landscape

The report sheds light on the leading providers of global drug delivery systems along with their detailed profiles. Essential and up-to-date data information related to market performers, who are principally engaged in the production of drug delivery systems, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permit the report readers to take preemptive steps in advancing their businesses.

Key Takeaways of Global Drug Delivery Systems Market Study:

  • By delivery type, targeted drug delivery shall grow at a CAGR of 6.8%, accounting for almost half of the global drug delivery systems market. However, polymeric drug delivery is expected to grow the fastest at the rate of 7.3% during the forecast period. Use of nanotechnology and localized drug delivery are key growth drivers for both segments.
  • By application, the oncology segment shall expand the fastest at a CAGR of 7.5% while the CNS segment shall grow at a CAGR of 6.9%. Rising prevalence of cancer and neurological disorders have boosted the demand for enhanced drug delivery devices, thus boosting the overall market share.
  • By route of administration, the injectables segment shall capture a major chunk of the global drug delivery systems market, constituting 44.6% market share. The oral segment is close behind, capturing nearly 2/5th of the global drug delivery systems market. Faster drug delivery at the affected site drives the growth of the injectables segment while advancements in oral drug formulations such as solid lipid nanoparticles shall drive the growth of the oral drugs segment.
  • By region, North America shall dominate the global drug delivery systems market, capturing nearly 40% of the market. At the same time, Asia-Pacific shall expand the fastest, at a CAGR of 7.8% across the forecast period. Increasing prevalence of acute chronic infections, introduction of advanced drug delivery devices and systems and favorable reimbursement policies for key players shall drive growth in both regions.

“Introduction of nanotechnology, coupled with three-dimensional printing and strengthening of existing and new drugs are poised to act as important growth stimulators of the global drug delivery systems market. Key manufacturers are exploiting the available opportunities to consolidate their foothold within the market,” concludes a Fact.MR analyst.

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4768

global drug delivery systems market 01
Report Benefits & Key Questions Answered

  • Drug Delivery Systems Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Drug Delivery Systems Historical volume analysis: The report provides a comparison of Drug Delivery Systems’s historical sales and projected sales performance for 2021-2031.
  • Drug Delivery Systems Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Drug Delivery Systems market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Drug Delivery Systems Consumption by demographics: The report investigates consumer behavior affecting Drug Delivery Systems demand outlook for the assessment period. Effect of their keenness for digital trends on Drug Delivery Systems market is carefully analyzed
  • Post COVID consumer spending on Drug Delivery Systems: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Drug Delivery Systems market growth.

More Valuable Insights on Drug Delivery Systems Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Drug Delivery Systems, Sales and Demand of Drug Delivery Systems, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

 

Categories
Pharmaceutical

Sales of Nasal Drug Delivery Systems Is Anticipated to Register a CAGR Growth of 7% by 2025

The ongoing COVID-19 pandemic is set to leverage the global drug delivery systems market, expanding at a CAGR of 7.0% between 2020 and 2025. As the number of infections rise exponentially on a daily basis, healthcare providers are grappling with rising shortfalls in the provision of essential medical equipment such as respirators and ventilators.

As a result, key players in the industry have scaled up their production in order to meet shortages. The easing of nationwide lockdowns and lifting of travel restrictions is anticipated to regenerate production cycles and supply chains, thus restoring the supply of drug delivery systems. In addition, the utilization of drug delivery systems for gene therapy will leverage the global drug delivery systems market.

For detailed insights on enhancing your product footprint, request a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=4768

The ongoing COVID-19 pandemic is set to leverage the global drug delivery systems market, expanding at a CAGR 7%.

between 2020 and 2025. As the number of infections rise exponentially on a daily basis, healthcare providers are grappling with rising shortfalls in the provision of essential medical equipment such as respirators and ventilators.

As a result, key players in the industry have scaled up their production in order to meet shortages. The easing of nationwide lockdowns and lifting of travel restrictions is anticipated to regenerate production cycles and supply chains, thus restoring the supply of drug delivery systems. In addition, the utilization of drug delivery systems for gene therapy will leverage the global drug delivery systems market.

For comprehensive insights on this market adoption, ask an analyst here- https://www.factmr.com/connectus/sample?flag=AE&rep_id=4768

global drug delivery systems market 01

Global Drug Delivery Systems: Market Segmentation

Fact.MR has studied the global drug delivery systems market with detailed segmentation on the basis of delivery system, route of administration, application and region.

Delivery System

  • Intra Uterine Implants
  • Pro-drug Implants
  • Polymeric Drug Delivery
  • Targeted Drug Delivery

Route of Administration

  • Oral
  • Injectable
  • Inhalation
  • Transdermal
  • Ocular
  • Nasal
  • Topical

Application

  • Infectious Disease
  • Oncology
  • Ophthalmology
  • Urology
  • Diabetes
  • CNS
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Key Takeaways of Global Drug Delivery Systems Market Study:

By delivery type, targeted drug delivery shall grow at a CAGR of 6.8%, accounting for almost half of the global drug delivery systems market. However, polymeric drug delivery is expected to grow the fastest at the rate of 7.3% during the forecast period. Use of nanotechnology and localized drug delivery are key growth drivers for both segments.
By application, the oncology segment shall expand the fastest at a CAGR of 7.5% while the CNS segment shall grow at a CAGR of 6.9%. Rising prevalence of cancer and neurological disorders have boosted the demand for enhanced drug delivery devices, thus boosting the overall market share.

By route of administration, the injectables segment shall capture a major chunk of the global drug delivery systems market, constituting 44.6% market share. The oral segment is close behind, capturing nearly 2/5th of the global drug delivery systems market. Faster drug delivery at the affected site drives the growth of the injectables segment while advancements in oral drug formulations such as solid lipid nanoparticles shall drive the growth of the oral drugs segment.
By region, North America shall dominate the global drug delivery systems market, capturing nearly 40% of the market. At the same time, Asia-Pacific shall expand the fastest, at a CAGR of 7.8% across the forecast period. Increasing prevalence of acute chronic infections, introduction of advanced drug delivery devices and systems and favorable reimbursement policies for key players shall drive growth in both regions.

“Introduction of nanotechnology, coupled with three-dimensional printing and strengthening of existing and new drugs are poised to act as important growth stimulators of the global drug delivery systems market. Key manufacturers are exploiting the available opportunities to consolidate their foothold within the market,” concludes a Fact.MR analyst.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4768

Presence of Several Global & Local Market Players to Heat up Market Competition:

The global drug delivery systems market is characterized by the presence of a large number of global and local manufacturers. Prominent players include, but are not limited to, the following: Novartis AG, Pfizer, Inc., Baxter International, Inc., Bayer AG Boston Scientific Corporation, Johnson and Johnson Services, Inc., Amgen, Inc., and F. Hoffmann La-Roche Ltd. Development of new drug delivery systems and addressing anomalies among existing ones are important expansion strategies adopted by the important market players.

For instance, Novartis AG has acquired a patent to develop thermogelling peptide delivery systems in February 2020. In addition, the company currently offers the Binocrit and ZYKADIA drugs for treating symptomatic anemia associated with renal failure and treatment of non-small lung cancer. Pfizer, Inc., another prominent market player, provides the iSecure, ABBOJECT and CARPUJECT syringe systems. Additionally, it also offers IV drug delivery systems such as the ADD-Vantage ADDaptor delivery system.

For More Insights: https://www.biospace.com/article/increased-healthcare-spending-and-technological-advancements-are-shaping-future-of-waldenstrom-macroglobulinemia-market-finds-fact-mr/

Looking for more information?

The research study on the global drug delivery systems market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global drug delivery systems market over 2020-2025. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026. Market statistics have been presented on the basis of delivery system (intra-uterine implants, pro-drug implants, polymeric drug delivery, and targeted drug delivery), route of administration (oral, injectable, inhalation, transdermal, ocular, nasal and topical) and application (infectious disease, oncology, ophthalmology, urology, diabetes, CNS and others) across five major regions.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com